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Summary The relationship between hepatic arterial albumin microsphere distribution and hepatic arterial
blood flow and the effects of regional angiotensin II were studied in a rat liver metastases model. Hooded-
Lister rats were inoculated subcapsularly with 2 x 106 HSN sarcoma cells. At 20 days, hepatic arterial blood
flow was measured using the reference microsphere technique. Animals then randomly received 501l hepatic
arterial saline or albumin microspheres (40jim, 20mgml-'). Hepatic arterial blood flow measurements were
then repeated at 5 min. After 5 min, animals were killed and tissues were weighed and counted in a gamma
well counter. There were no significant differences between the hepatic blood flow measurements recorded
before and after the control hepatic arterial saline infusion. However, regional albumin microspheres produced
a significant reduction in tumour and normal liver blood flow and an 80% reduction in mean T/N blood flow
ratio. Regional albumin microspheres were delivered to tumour in greater proportions (mean T/N ratio 3.89,
SE 0.49) than would be expected from baseline hepatic arterial blood flow (mean T/N ratio 1.28, SE 0.22.
P = 0.006). There was no correlation between T/N for baseline blood flow and albumin microsphere distribu-
tion.
Drug-loaded or radioactive microspheres may be administer-
ed via the hepatic artery for the treatment of liver metastases
(Herba et al., 1988; McArdle et al., 1988). It has generally
been assumed that such embolic particles are distributed to
tumour and normal liver in proportion to their respective
arterial blood flows. However, recent work in a rat liver
tumour model has shown that the distribution of albumin
microspheres to tumour relative to normal liver (T/N ratio)
varies significantly with both microsphere diameter and con-
centration; larger, more concentrated microspheres tend to
produce higher T/N ratios than those obtained with dilute
suspensions of small microspheres (Anderson et al., 1991).
The reasons underlying these observed differences in T/N
ratios and their relationship to the distribution of hepatic
arterial blood flow are not understood. Furthermore, the
effects of regional microsphere delivery on hepatic arterial
blood flow require elucidation.
Enhancement of the T/N ratio may be achieved with drug-
induced modification of liver blood flow. Vasoactive agents,
such as angiotensin II, induce vasoconstriction in normal
liver whilst tumour vessels, which lack smooth muscle,
remain dilated. Therefore microspheres administered after
angiotensin II are targeted to tumour (Goldberg et al., 1991).
It is not known whether the optimum T/N ratio achieved
with large, concentrated microspheres can be potentiated
with vasoactive agents.
The aims of the present study, therefore, were to clarify the
relationship between microsphere distribution and hepatic
blood flow and to assess the possibility of further T/N ratio
potentiation using angiotensin II.
Materials and methods
Tumour model
Male Hooded-Lister rats, weighing 150-200 g, received an
intraperitoneal pentobarbitone (60 mg kg-') general anaes-
thetic. Through a short, midline incision, the liver was inocu-
lated subcapsularly with 106 HSN sarcoma cells into the
median and the left lobes (one inoculation per lobe). The
HSN sarcoma was originally induced in a male Hooded-
Lister rat with 3-4-benzpyrene (Currie & Gage, 1973). All
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subsequent experiments were undertaken at 20 days when
macroscopic tumour was present.
Albumin microspherepreparation
Radiolabelled microspheres were prepared as previously des-
cribed (Willmott et al., 1985). Briefly, human serum albumin
(190mg) was added to 10 mg 125I iodinated albumin (1 mCi)
(Amersham International) and dissolved in I mM phosphate
buffer containing 0.1% sodium dodecyl sulphate (0.4ml)
then diluted with water (0.5 ml). The resulting solution was
emulsified in an oil phase of cottonseed oil/petroleum ether
and the protein was cross-linked with gluteraldehyde (100gIl,
12.5%) to stabilise the microspheres. Stirring rate was
1,200 r.p.m. during the formation of the water-in-oil emul-
sion. After consecutive differential centrifugation steps in
petroleum ether, isopropanol and PBS + 0.5% Tween 80 to
remove particles smaller than 3 rim, the volume-weighted
mean microsphere diameter was 40 tsm as assessed by laser
diffraction measurements. Eighty per cent of microspheres
were in the range 18-54 jLm.
Following washing in physiological saline, microspheres
were ready for use. They were suspended in 0.9% saline with
0.01% Tween 80 in a concentration of 20 mg ml- (2.7 x 1O'
microspheresml-'). More than 99% of radioactivity was
associated with microspheres. Their in vivo half-life in rat
liver is 3.6 days and 125I leaching is only 1.6% at 9 days when
microspheres are incubated at 37°C in rat serum (Willmott et
al., 1989).
Bloodflow measurements and distribution ofintra-arterial
microspheres
Animals were fasted overnight prior to undergoing reference
sample blood flow estimations based on the technique of
Malik et al. (1976) which were performed before and after
the hepatic arterial administration of saline or albumin
microspheres. An intraperitoneal pentobarbitone general
anaesthetic was administered and tracheostomy was perform-
ed. The animal breathed oxygen enriched room air spon-
taneously. A temperature probe was inserted into the rectum
and core temperature was maintained between 35.5 and 370C
using a heat lamp. Polythene cannulae (I.D. 0.58 mm) were
then inserted into the right carotid and both femoral arteries.
The carotid artery cannula was advanced as far as the left
ventricle and its position was confirmed by the subsequent
change in pulse pressure recorded via that cannula. Blood
pressure was recorded thereafter via one of the femoral
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artery cannulae using a Statham pressure transducer. The
other femoral artery cannula was attached to a 2 ml syringe
on a withdrawal pump for collection of the reference blood
samples. Through a midline abdominal incision, a further
polythene cannula was inserted into the gastroduodenal
artery and held with a silk ligature so that its tip lay just
distal to its origin from the hepatic artery. Flow in the
hepatic artery was observed not to be obstructed by the
cannula.
Approximately I05 of 15 tim resin microspheres (DuPont),
radiolabelled with either 57Co or '53Gd, were suspended in
0.2 ml 0.9% saline with 0.01% Tween 80 and infused into the
left ventricle over 20 s. The microspheres were agitated with a
rotamixer for 1 min prior to administration. A reference
blood sample was withdrawn at 0.5 ml min-' for 1 min start-
ing immediately before the microsphere infusion. Blood pres-
sure stability was confirmed and, after 5 min had elapsed,
50 ttl of 0.9% saline (Group 1) or 1251I radiolabelled albumin
microspheres (Group 2) were infused into the hepatic artery
over 30 s. Blood pressure stability was confirmed again and a
further 5 min were allowed to elapse before a second intra-
ventricular radiolabelled resin microsphere injection with
reference blood sampling was undertaken. The order of resin
microsphere administration (57Co or '53Gd) was randomised.
After a further 5 min the animal was killed with an intravent-
ricular pentobarbitone bolus.
Liver, kidneys, stomach, spleen and intestines were remov-
ed, tumour was dissected from normal liver, and these tissues
were weighed and counted in a gamma well counter (Packard
500C) with appropriate window settings for counting, 57Co,
153Gd and (in Group 2) 1251. Pure samples of the radio-
isotopes were also counted to allow correction for spillover
of counts between channels. Animals with a fall in mean
blood pressure of more than 15 mmHg following any of the
injections were rejected. Experiments were also rejected if the
counts associated with either of the intraventricular injections
differed by greater than 10% between left and right kidneys
since this was assumed to reflect incomplete mixing of the
microspheres with blood. Furthermore, group 2 experiments
where excessive number of albumin microspheres had flowed
retrogradely in the hepatic artery (as assessed by the 125I
activity in stomach, spleen and intestines relative to hepatic
1251I activity) were rejected.
Blood flow to tumour and normal liver (mgg-'minm'),
before and after the regional injection of saline or albumin
microspheres, was calculated from the distribution of 57Co
and '53Gd radioactivity using the formula:
Blood flow (mlmin- g-1) =
Radioactivity/g tissue x Reference sample withdrawal rate (ml min ')
Radioactivity in reference sample
The distribution of the regional albumin microspheres were
characterised by calculating the tumour to normal liver (T/N)
ratio:
T/N ratio '1251 radioactivity g' tumour
1251 radioactivity g-' normal liver
Effect ofangiotensin II on regional microsphere distribution
The T/N ratio for regional albumin microspheres (Group 2)
was compared with the T/N ratio achieved following an
angiotensin II infusion. The gastroduodenal artery was can-
nulated and angiotensin II (50 ftl of 5 lAg ml-' solution) was
infused over 30 s. This was followed 1 min later by 50 tlI of
125I radiolabelled albumin microspheres (Group 3). After a
further 5 min, the animal was killed with an intraventricular
pentobarbitone bolus. The liver was removed and the T/N
ratio for albumin microspheres was measured as previously
described.
Data analysis
The data were analysed using the paired and unpaired
Student's t-tests and linear regression and correlation ana-
lysis.
Results
Group I
Blood flow measurements before and after administration of
hepatic arterial saline are shown in Table I. No significant
differences in normal liver blood flow, tumour blood flow or
the ratio of tumour to normal liver blood flow were observed.
Regional saline therefore does not affect the level or distribu-
tion of hepatic arterial blood flow at 5 min after infusion.
Group 2
Normal liver and tumour blood flow were both reduced
5 min after regional albumin microsphere administration
(Table I). This blood flow reduction was considerably greater
in tumour compared with normal liver, leading to an 80%
reduction in mean T/N blood flow ratio.
T/N ratios for baseline hepatic arterial blood flow and
regional albumin microsphere distribution are shown in
Table II. Regional albumin microspheres were delivered to
tumour in greater proportions (mean T/N ratio 3.89, SE
0.49) than would be expected from baseline hepatic arterial
blood flow (mean T/N ratio 1.28, SE 0.22, P = 0.006, paired
t-test). There was no significant correlation between the T/N
ratios for baseline blood flow and albumin microsphere dist-
ribution (r =-0.15, P = 0.77).
Group 3
Angiotensin II enhanced the T/N ratio for regional albumin
microspheres but this did not reach statistical significance.
Mean T/N ratio was 5.01 (SE 0.43, n = 6) following angio-
tensin II compared with 3.89 (SE 0.49) without angiotensin II
(P = 0.12, unpaired t-test). The tumour burden in group 3
(mean 3.4 g, SE 0.4) was greater than in group 2 (mean 2.1 g,
SE 0.6) but this did not reach statistical significance.
Discussion
The principal aim of regional therapy is to maximise the
proportion of a given therapeutic agent that is delivered to
the tumour, thereby increasing efficacy and restricting tox-
Table I Normal liver hepatic arterial blood flow, tumour hepatic
arterial blood flow and T/N ratio ofhepatic arterial blood flow before
and after hepatic arterial saline or albumin microspheres
Saline (n = 5) Albumin (n = 6)
Mean SE Mean SE
Normal liver blood flow (ml 100 g' min ')
Pre 23.2 6.4 16.1 3.8
Post 22.7 4.9 7.1 1.9 **
Tumour blood flow (ml 100 g- min-')
Pre 22.0 8.3 21.2 7.6
Post 24.9 8.5 1.6 0.6 *
T/N blood flow ratio
Pre 0.91 0.28 1.28 0.22
Post 1.06 0.33 0.25 0.09 **
*P<0.05, **P<0.01 for pre vs post albumin microspheres (Stu-
dent's paired t-test).
Table II T/N ratios for baseline hepatic arterial blood flow and
regional albumin microsphere distribution
Reference resin microsphere Regional albumin microsphere
Animal TIN ratio T/N ratio
1 1.92 2.44
2 1.72 3.72
3 0.77 5.08
4 0.68 2.62
5 1.6 5.28
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icity. Administration of microspheres via the hepatic artery
achieves first level targeting to the tumour-bearing organ,
but further measures are required to limit therapy to metas-
tases rather than normal hepatic tissue. Our previous studies
(Anderson et al., 1991), have demonstrated that concentrated
(20mgml-'), large (40,Lm), regional albumin microspheres
produce significantly higher T/N ratios than can be obtained
with small (12.5 um), dilute (0.2 mg ml-') microspheres.
However, it was not clear whether the distribution of any of
the microsphere preparations studied was related to the
distribution of hepatic arterial blood flow. This question is
important not only for the understanding of the factors
governing the distribution of therapeutic microspheres, but
also for assessing the potential value of haemodynamic inves-
tigations in predicting the outcome of regional therapy.
In the present study we compared the distribution of the
therapeutic microspheres that produced the optimum T/N
ratios with the corresponding blood flow distribution as
measured by a standard reference microsphere technique
(Malik et al., 1976). Despite approximately equivalent blood
flow to tumour and normal liver prior to the regional injec-
tion, the potentially therapeutic albumin microspheres were
delivered preferentially to tumour, with a near 4-fold concen-
tration advantage.
The T/N ratio for albumin microspheres could not be
predicted from the blood flow ratio. Blood flow determina-
tions before and after a regional saline infusion (Group 1)
demonstrated the reproducibility of the measurement techni-
que in this animal model. It is therefore unlikely that the
distribution of regional albumin microspheres was influenced
by hepatic blood flow disturbances caused by the first intra-
ventricular resin microsphere injection. The present study
therefore exclude pre-existing haemodynamic conditions as a
major determinant of the distribution of regional albumin
microspheres when administered as a concentration suspen-
sion.
It has been proposed that hepatic arterial blood flow dis-
turbances following administration of concentrated cytotoxic
microspheres could be likened to the effects of degradable
starch microspheres. Dynamic flow scintigraphic studies in
human subjects have revealed flow dislocation from areas of
high resting flow to those with low resting flow following
administration of 45-90 x 106 of these 40 Lm particles in a
volume of 50 ml (Civalleri et al., 1989). Microspheres that are
administered early in a concentrated infusion might tend to
go to high flow areas resulting in embolisation which leads to
distribution of the latter portion of microspheres to relatively
hypovascular areas. However, in the present experimental
series there was little difference in baseline perfusion of
tumour and normal liver, and it seems more likely that the
critical difference lies in the structure and function of the
blood vessels. Tumour blood vessels are believed to have
little capacity to alter their tone as they are deficient in
smooth muscle and adrenergic receptors (Krylova, 1969) and
it is possible that the microspheres are diverted to tumour by
a selective, transient vasoconstriction in normal liver. Subse-
quent near-total occlusion of the tumour circulation by the
albumin microspheres might explain why the fall in blood
flow to tumour was so much greater than that observed in
normal liver (Group 2). Clearly some form of dynamic study
during regional microsphere administration is required to
resolve these questions.
Angiotensin II provided further enhancement of the T/N
ratio beyond that achieved by selecting the optimum micro-
sphere size and concentration, although the difference was
not statistically significant. Higher T/N ratios may be assoc-
iated with small tumours since large tumours tend to become
avascular in their core (Ackerman, 1974). However, in the
present study there was no evidence that observed differences
in T/N ratios between Groups 2 and 3 could be accounted
for by differences in tumour sizes between groups.
In conclusion, the use of large, concentrated albumin mic-
rospheres for regional delivery to the liver provides a higher
T/N ratio than might be predicted from baseline hepatic
arterial blood flow. Regional albumin microspheres reduce
both tumour and normal liver blood flow at 5 min, with a
relatively greater reduction in tumour. Angiotensin II further
enhances the T/N ratio for large, concentrated, regional
albumin microspheres. However it should be recognised that
these results were observed in an animal tumour model and it
remains uncertain whether these conclusions would be valid-
ated in the human situation.
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